Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved N-Acetylgalactosamine–Conjugated RNA Interference Therapeutic
Jing Li, Ju Liu, Xuemei Zhang, Valerie A. Clausen, Chris Tran, Michael Arciprete, Qianfan Wang, Carrie Rocca, Lihua Guan, Guodong Zhang, Diana Najarian, Yuanxin Xu, Pete Smith, Jing‐Tao Wu, Saeho Chong (2021). Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved N-Acetylgalactosamine–Conjugated RNA Interference Therapeutic. , 49(7), DOI: https://doi.org/10.1124/dmd.121.000381.
Article140 days agoThe Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of N-Acetylgalactosamine–Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to Human
Robin McDougall, Diane Ramsden, Sagar Agarwal, Saket Agarwal, Krishna Aluri, Michael Arciprete, Christopher R. Brown, Elena Castellanos-Rizaldos, Klaus Charissé, Saeho Chong, Joseph A. Cichocki, Kevin Fitzgerald, Varun Goel, Yongli Gu, Dale C. Guenther, Bahru Habtemariam, Vasant Jadhav, Maja M. Janas, Muthusamy Jayaraman, Jeffrey C. Kurz, Jing Li, Ju Liu, Xiumin Liu, Steven Liou, Chris Maclauchlin, Martin A. Maier, Muthiah Manoharan, Jayaprakash K. Nair, Gabriel J. Robbie, Karyn Schmidt, Pete Smith, Christopher S. Theile, Akshay Vaishnaw, Scott Waldron, Yuanxin Xu, Xuemei Zhang, Ivan Zlatev, Jing‐Tao Wu (2021). The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of N-Acetylgalactosamine–Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to Human. , 50(6), DOI: https://doi.org/10.1124/dmd.121.000428.
Article140 days ago